Avenue Supermarts Limited
General Updates
Avenue Supermarts Limited has informed the Exchange about the repayment of commercial paper, with the maturity proceeds paid to the holder as per details provided.
BSE & NSE corporate filings with AI summaries
Avenue Supermarts Limited
Avenue Supermarts Limited has informed the Exchange about the repayment of commercial paper, with the maturity proceeds paid to the holder as per details provided.
Lloyds Metals And Energy Limited
Lloyds Metals and Energy Limited's Q2 and H1 FY27 earnings conference call transcript is available on the company's website, with the management discussing the company's performance, future plans, and competitive advantages.
Olectra Greentech Ltd
Olectra Greentech Ltd announced its un-audited financial results for the second quarter and half year ended September 30, 2026, with revenue from operations at Rs. 67,737.31 lakhs and total income at Rs. 69,229.97 lakhs. The company also approved the sale of its 34% equity shareholding in Evey Trans (UJJ) Private Limited to Evey Trans Private Limited for Rs. 34,000.
Ramkrishna Forgings Ltd
Ramkrishna Forgings Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Riddhi Portfolio Pvt Ltd & PACs.
Aptus Value Housing Finance India Limited
Aptus Value Housing Finance India Limited has informed the Exchange about the schedule of an investor/analyst meeting to be held on November 11, 2026, with Morgan Stanley. The company has also uploaded the investor presentation on its website and intimated the stock exchanges.
Olectra Greentech Limited
Olectra Greentech Limited has submitted its financial results for the period ended September 30, 2026, and announced the sale of its entire 34% equity shareholding in Evey Trans (UJJ) Private Limited to Evey Trans Private Limited for Rs. 34,000.
Petronet LNG Ltd
Petronet LNG Ltd reported unaudited financial results for Q2 FY27, with PBT of INR1,659 crores and PAT of INR1,235 crores, representing a growth of 10% and 9% sequentially, and 53% and 53% year-on-year, respectively. The company's utilization percentages for the current and previous quarters are based on Dahej's expanded capacity of 22.5 million ton per annum.
Regaal Resources Limited
Regaal Resources Limited has informed the Exchange about Schedule of Earnings Conference Call for the Q2 & H1 FY27.
SML Mahindra Ltd
SML Mahindra Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Anandam Enterprises & PACs, indicating a potential change in control or significant stake acquisition.
Nuvama Wealth Management Limited
Nuvama Wealth Management Limited has informed the Exchange about Schedule of meet for Analysts/Institutional Investor Meeting(s) on November 16 and 26, 2026, where the company's representatives will discuss the Investor Presentation for the quarter and half year ended September 30, 2026.
Nuvama Wealth Management Limited
Nuvama Wealth Management Limited has informed the Exchange about Schedule of meet for Analysts/Institutional Investor Meeting(s) on November 16 and 26, 2026, where the company's representatives will discuss the Investor Presentation for the quarter and half year ended September 30, 2026.
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange about the schedule of Analyst/ Institutional Investor meetings to be conducted from November 16, 2026 to November 18, 2026 in Taiwan and Singapore, and on November 23, 2026 in Switzerland.
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange about the schedule of Analyst/ Institutional Investor meetings to be conducted from November 16, 2026 to November 18, 2026 in Taiwan and Singapore, and on November 23, 2026 in Switzerland. The meetings may undergo changes due to exigencies.
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange about the schedule of an Analyst/ Institutional Investor meeting to be conducted from November 16-18, 2026, in Taiwan and Singapore, and on November 23, 2026, in Switzerland. The meeting will be held for both physical and one-on-one meetings with investors.
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange about the schedule of Analyst/ Institutional Investor meetings to be conducted between November 16, 2026, and November 23, 2026, in Taiwan, Singapore, and Switzerland. The meetings will be conducted both physically and virtually, and no unpublished price-sensitive information will be shared during the meetings.
Xpro India Limited
Xpro India Limited hosted an earnings conference call for Q2 and H1 FY27, discussing their results and key developments. The company's Managing Director, C. Bhaskar, introduced the call and highlighted their diversified multi-locational business, primarily focused on polymer processing. Xpro has manufacturing facilities in India and the UAE, and specializes in advanced materials, including polypropylene dielectric capacitor films. The company's results for the quarter and half year ended September 30, 2026, have been uploaded to stock exchange portals and their website.
Avenue Supermarts Ltd
Avenue Supermarts Ltd has repaid its commercial paper worth Rs. 300 Crores on November 9, 2026, as per the SEBI Master Circular.
Alufluoride Ltd
Alufluoride Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/11/2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30, 2026.
Vinati Organics Ltd-$
Vinati Organics Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Suchir Chemicals Pvt Ltd.
Regaal Resources Ltd
Regaal Resources Ltd has announced the schedule of its earnings conference call for Q2 & H1 FY27, to be held on November 16, 2026, at 11:30 A.M. The call will be represented by the company's management, including the Chairman and Managing Director, Whole-time Director, and Chief Financial Officer.